Opioid exposure in haemophilia patients is common and underreported.
Skye J PeltierMarshall A MazepaRebecca L FreeseShannon F NelsonSusan L KearneyMark T RedingPublished in: Haemophilia : the official journal of the World Federation of Hemophilia (2020)
This is the first study in the haemophilia population to examine opioid exposure based on prescription data. Opioid exposure was more common than predicted in both adult and paediatric study populations and was most often prescribed for acute pain or procedures by non-HTC providers. Haemophilia treatment centres need to take the lead in assessing pain in haemophilia patients, guiding treatment promoting non-opioid options, strengthen efforts to monitor opioid exposure and collect data on pain treatment in the haemophilia population.
Keyphrases
- chronic pain
- pain management
- end stage renal disease
- ejection fraction
- chronic kidney disease
- newly diagnosed
- neuropathic pain
- peritoneal dialysis
- intensive care unit
- emergency department
- combination therapy
- spinal cord injury
- patient reported outcomes
- artificial intelligence
- big data
- data analysis
- respiratory failure